Cargando…

EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece

Detalles Bibliográficos
Autores principales: Athanasakis, K, Nomikos, N, Tsoulas, C, Zisis, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747494/
http://dx.doi.org/10.1016/j.jval.2022.09.768
_version_ 1784849612656345088
author Athanasakis, K
Nomikos, N
Tsoulas, C
Zisis, K
author_facet Athanasakis, K
Nomikos, N
Tsoulas, C
Zisis, K
author_sort Athanasakis, K
collection PubMed
description
format Online
Article
Text
id pubmed-9747494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97474942022-12-14 EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece Athanasakis, K Nomikos, N Tsoulas, C Zisis, K Value Health Article Published by Elsevier Inc. 2022-12 2022-12-14 /pmc/articles/PMC9747494/ http://dx.doi.org/10.1016/j.jval.2022.09.768 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Athanasakis, K
Nomikos, N
Tsoulas, C
Zisis, K
EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
title EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
title_full EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
title_fullStr EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
title_full_unstemmed EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
title_short EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece
title_sort ee527 cost-effectiveness and budget impact analysis of remdesivir for the treatment of covid-19 in greece
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747494/
http://dx.doi.org/10.1016/j.jval.2022.09.768
work_keys_str_mv AT athanasakisk ee527costeffectivenessandbudgetimpactanalysisofremdesivirforthetreatmentofcovid19ingreece
AT nomikosn ee527costeffectivenessandbudgetimpactanalysisofremdesivirforthetreatmentofcovid19ingreece
AT tsoulasc ee527costeffectivenessandbudgetimpactanalysisofremdesivirforthetreatmentofcovid19ingreece
AT zisisk ee527costeffectivenessandbudgetimpactanalysisofremdesivirforthetreatmentofcovid19ingreece